Bank of New York Mellon Corp raised its stake in shares of Humana Inc. (NYSE:HUM) by 12.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,818,410 shares of the insurance provider’s stock after buying an additional 208,344 shares during the period. Bank of New York Mellon Corp owned approximately 1.22% of Humana worth $321,658,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the stock. Point72 Asia Hong Kong Ltd purchased a new stake in Humana during the second quarter valued at about $126,000. Daiwa SB Investments Ltd. raised its stake in Humana by 1.4% in the third quarter. Daiwa SB Investments Ltd. now owns 730 shares of the insurance provider’s stock valued at $129,000 after buying an additional 10 shares during the last quarter. Markston International LLC purchased a new stake in Humana during the third quarter valued at about $159,000. Bessemer Group Inc. raised its stake in Humana by 14.0% in the second quarter. Bessemer Group Inc. now owns 1,140 shares of the insurance provider’s stock valued at $205,000 after buying an additional 140 shares during the last quarter. Finally, Fulton Bank N.A. purchased a new stake in Humana during the third quarter valued at about $229,000. 91.71% of the stock is currently owned by institutional investors.

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Shares of Humana Inc. (NYSE:HUM) opened at 208.00 on Tuesday. The stock’s 50 day moving average is $182.87 and its 200-day moving average is $177.74. The firm has a market cap of $31.01 billion, a P/E ratio of 28.13 and a beta of 0.80. Humana Inc. has a one year low of $150.00 and a one year high of $210.30.

Humana (NYSE:HUM) last issued its earnings results on Friday, November 4th. The insurance provider reported $3.18 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $3.09 by $0.09. The business had revenue of $13.69 billion for the quarter, compared to the consensus estimate of $13.41 billion. Humana had a net margin of 2.00% and a return on equity of 12.32%. The business’s quarterly revenue was up 2.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.16 earnings per share. Analysts anticipate that Humana Inc. will post $9.51 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, January 27th. Stockholders of record on Thursday, January 12th will be issued a $0.29 dividend. This represents a $1.16 annualized dividend and a dividend yield of 0.56%. The ex-dividend date of this dividend is Tuesday, January 10th. Humana’s payout ratio is 15.96%.

ILLEGAL ACTIVITY NOTICE: This story was originally posted by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are accessing this story on another website, it was illegally copied and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this story can be viewed at https://www.thecerbatgem.com/2016/11/29/bank-of-new-york-mellon-corp-acquires-208344-shares-of-humana-inc-hum.html.

Several equities research analysts have recently issued reports on HUM shares. JPMorgan Chase & Co. raised shares of Humana from a “neutral” rating to an “overweight” rating and increased their target price for the stock from $163.00 to $202.00 in a research note on Thursday, November 10th. Argus reissued a “hold” rating on shares of Humana in a research note on Tuesday, August 23rd. Barclays PLC reissued a “hold” rating and set a $191.00 target price on shares of Humana in a research note on Monday, November 7th. Credit Suisse Group AG raised shares of Humana from a “neutral” rating to an “outperform” rating and increased their target price for the stock from $175.00 to $210.00 in a research note on Friday, November 11th. Finally, Zacks Investment Research raised shares of Humana from a “hold” rating to a “buy” rating and set a $198.00 target price on the stock in a research note on Tuesday, October 4th. Five investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $205.00.

Humana Company Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

5 Day Chart for NYSE:HUM

Receive News & Stock Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related stocks with our FREE daily email newsletter.